Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks

Gerresheimer has an analyst consensus of Strong Buy, with a price target consensus of €109.73, a 65.65% upside from current levels. In a report released on December 20, Jefferies also maintained a Buy rating on the stock with a €93.00 price target.

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.

Gerresheimer AG provides specialty glass and plastic products to the pharmaceutical and healthcare industry. The firm operates in three segments: plastics and devices, primary packaging glass and advanced technologies. The plastics and devices segment sells products for drug administration, including insulin pens, inhalers, prefillable syringes, and plastic packaging for medications. The primary packaging glass segment produces glass packaging products for drugs and cosmetics, such as injection vials, cartridges, and jars. The advanced technologies segment develops and manufactures intelligent drug delivery systems. Gerresheimer generates the majority of its revenue in Europe, with sales in Germany contributing the largest proportion of any country.